Close
Nordic 9Nordic 9

Prime Movers Labs (investor - Venture Capital)

United States primemoverslab.com
See something wrong or missing? Let us know
Offices:New York

Prime Movers Lab invests in scientific startups active in energy, transportation, infrastructure, manufacturing, human augmentation, and agriculture

Average round investment:90M USD
Average number per year:2.0
Distribution: 2021 (2)
Portfolio companies: Switzerland Energy VaultUnited Kingdom Beckley Psytech
Mostly invests in: Switzerland Switzerland (1) Manufacturing (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Prime Movers Labs

Name Criteria
United States Helena Projects
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Software Services, Energy
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Idealab
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Software Services, Energy
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Netherlands Exor
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Software Services, Energy, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Bristol-Myers Squibb
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Software Services, Pharma, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Netherlands Gilde Healthcare
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Software Services, Pharma, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States Palo Santo
81%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Pharma, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Integrated
81%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Pharma, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Adage Capital Management
81%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Pharma, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Negev Capital
81%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Pharma, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
China GT Healthcare Capital
81%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Software Services, Pharma, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top